-
Clinical-stage biopharmaceutical company AEON Biopharma (New York Stock Exchange: Aeon) initiated a public offering to sell units, which consist of common shares and warrants to purchase shares.
-
Additionally, the company expects to grant Aegis Capital Corp. a 45-day option to purchase additional shares, representing up to